Who responds best to Clomid ?

Nelson Vergel

Founder, ExcelMale.com
WHO IS THE MOST SUITABLE CANDIDATE FOR CLOMIPHENE TREATMENT? FINDINGS OF AN OBSERVATIONAL SURVEY IN A COHORT OF PRIMARY INFERTILE MEN

Comment from Nelson: Younger, thinner and with a bigger left testicle at baseline did better.

INTRODUCTION AND OBJECTIVES
Clomiphene has been widely used in idiopathic oligoasthenoteratozoospermia without proven evidence for its benefit. We assessed i) seminal outcomes after clomiphene treatment; and, ii) the most suitable candidate for clomiphene in a cohort of white-European men presenting for primary couple's infertility.

METHODS
Complete data from 307 consecutive men treated with clomiphene were analyzed. Comorbidities were scored with the Charlson Comorbidity Index (CCI; categorized 0 vs ≥1). Testicular volume (TV) was assessed with a Prader orchidometer. Semen analysis values were assessed based on the 2010 WHO reference criteria. Descriptive statistics tested the association between seminal outcome after therapy and clinical characteristics; logistic regression models tested the association between clinical parameters and clomiphene-related seminal improvement.

RESULTS
Mean (SD) age and duration of infertility was 43.36 (6.4) yrs and 28.27 (19.12) months, respectively. Baseline serum levels FSH, LH, inhibin B, AMH and total testosterone were 6.2 (4.7) mUI/mL, 4.9 (10.3) mUI/mL, 115.2 (66.7) pg/mL, 8.9 (14.2) ng/mL, and 5.0 (2.1) ng/mL, respectively. Overall, 194 (63.2%), 190 (61.9%) and 146 (47.6%) men presented with oligospermia, astenozoospermia and teratozoospermia, respectively. After 3 months of clomiphene, sperm concentration [pre vs post: 8.95 (7.5) vs 15.4 (14.11) million/mL; p<0.001] and total sperm progressive motility [11.81 (12.1) vs 18.9 (17.1); p<0.001] significantly improved. Improvement of sperm concentration was more frequently reported in younger individuals (p<0.001), with a lower BMI score (p=0.002), and with a higher left TV (p=0.03). Similar findings were also found for sperm motility (all p<0.05). Moreover, young patients (p<0.001), patients with normal BMI (p=0.02), and those with a greater left TV (p=0.003) were more likely to fall within the normal range of sperm concentration and sperm motility (all p<0.05) after treatment, respectively. At MVA, age (OR 0.86; p=0.005), BMI (OR 0.8; p=0.023) and lenght of infertility (OR 0.95; p=0.46) achieved independent predictor status for concentration improvement after clomiphene.

CONCLUSIONS
Clomiphene treatment was associated with an improvement of sperm concentration in a cohort of white-European men presenting for primary couples infertility. Patients who most benefited from this therapy are young, with a normal BMI and a short period of infertility.

Source of Funding: none


The Journal of Urology
Volume 193, Issue 4, Supplement, April 2015, Pages e946&#8211;e947

2015 Annual Meeting Program Abstracts

AUA Annual Meeting
 
Last edited:

hCG Mixing Calculator

HCG Mixing Protocol Calculator

TRT Hormone Predictor Widget

TRT Hormone Predictor

Predict estradiol, DHT, and free testosterone levels based on total testosterone

⚠️ Medical Disclaimer

This tool provides predictions based on statistical models and should NOT replace professional medical advice. Always consult with your healthcare provider before making any changes to your TRT protocol.

ℹ️ Input Parameters

Normal range: 300-1000 ng/dL

Predicted Hormone Levels

Enter your total testosterone value to see predictions

Results will appear here after calculation

Understanding Your Hormones

Estradiol (E2)

A form of estrogen produced from testosterone. Important for bone health, mood, and libido. Too high can cause side effects; too low can affect well-being.

DHT

Dihydrotestosterone is a potent androgen derived from testosterone. Affects hair growth, prostate health, and masculinization effects.

Free Testosterone

The biologically active form of testosterone not bound to proteins. Directly available for cellular uptake and biological effects.

Scientific Reference

Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64.

DOI: 10.1210/jc.2010-0102 | PMID: 20534765 | PMCID: PMC2913038

Beyond Testosterone Podcast

Online statistics

Members online
0
Guests online
507
Total visitors
507

Latest posts

Back
Top